Search research articles
Contact Us
Filters
Showing results (51-60 of 97) with videos related to
Page
of 10
Sort By:
Technology in Cancer Research & Treatment
|
September 5, 2013
In vivo assessment of HER2 receptor density in HER2-positive tumors by near-infrared imaging, using repeated injections of the fluorescent probe
Yasaman Ardeshirpour, Moinuddin Hassan, Rafal Zielinski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 3, 2021
Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
Jacek Capala, Stephen A Graves, Aaron Scott, et al.
Chembiochem : a European Journal of Chemical Biology
|
January 7, 2010
HER2- and EGFR-specific affiprobes: novel recombinant optical probes for cell imaging
Ilya Lyakhov, Rafal Zielinski, Monika Kuban, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 3, 2021
Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns
Richard L Wahl, George Sgouros, Amir Iravani, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 20, 2011
Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes)
Brandon Smith, Ilya Lyakhov, Kristin Loomis, et al.
Frontiers in Oncology
|
March 22, 2021
Radiopharmaceutical Validation for Clinical Use
Charles A Kunos, Rodney Howells, Aman Chauhan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 14, 2012
Potential of PET to predict the response to trastuzumab treatment in an ErbB2-positive human xenograft tumor model
Gabriela Kramer-Marek, Merel Gijsen, Dale O Kiesewetter, et al.
Molecular Imaging
|
August 23, 2007
Fluorescence lifetime imaging system for in vivo studies
Moinuddin Hassan, Jason Riley, Victor Chernomordik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging
Sang Bong Lee, Moinuddin Hassan, Robert Fisher, et al.
Translational Oncology
|
March 8, 2016
Preclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and Recommendations
Helen B Stone, Eric J Bernhard, C Norman Coleman, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 97) with videos related to
Sort By:
Page
of 10
Technology in Cancer Research & Treatment
|
September 5, 2013
In vivo assessment of HER2 receptor density in HER2-positive tumors by near-infrared imaging, using repeated injections of the fluorescent probe
Yasaman Ardeshirpour, Moinuddin Hassan, Rafal Zielinski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 3, 2021
Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
Jacek Capala, Stephen A Graves, Aaron Scott, et al.
Chembiochem : a European Journal of Chemical Biology
|
January 7, 2010
HER2- and EGFR-specific affiprobes: novel recombinant optical probes for cell imaging
Ilya Lyakhov, Rafal Zielinski, Monika Kuban, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 3, 2021
Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns
Richard L Wahl, George Sgouros, Amir Iravani, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 20, 2011
Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes)
Brandon Smith, Ilya Lyakhov, Kristin Loomis, et al.
Frontiers in Oncology
|
March 22, 2021
Radiopharmaceutical Validation for Clinical Use
Charles A Kunos, Rodney Howells, Aman Chauhan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 14, 2012
Potential of PET to predict the response to trastuzumab treatment in an ErbB2-positive human xenograft tumor model
Gabriela Kramer-Marek, Merel Gijsen, Dale O Kiesewetter, et al.
Molecular Imaging
|
August 23, 2007
Fluorescence lifetime imaging system for in vivo studies
Moinuddin Hassan, Jason Riley, Victor Chernomordik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging
Sang Bong Lee, Moinuddin Hassan, Robert Fisher, et al.
Translational Oncology
|
March 8, 2016
Preclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and Recommendations
Helen B Stone, Eric J Bernhard, C Norman Coleman, et al.
Page
of 10